Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:10 AM
Ignite Modification Date:
2025-12-25 @ 4:10 AM
NCT ID:
NCT00099320
Eligibility Criteria:
Inclusion Criteria:
* Treated with thiazolidinedione (TZD) alone or in combination with metformin. TZD dose stable for at least 120 days prior to screening, and those patients on metformin must have been on a stable dose for at least 30 days prior to screening.
* HbA1c between 7.1% and 10.0%, inclusive.
* Body mass index (BMI) between 25 kg/m\^2 and 45 kg/m\^2.
Exclusion Criteria:
* Patient previously in a study using exenatide or GLP-1 analogs.
* Treated with oral anti-diabetic medications other than TZD and metformin within 3 months of screening.
* Treated with oral insulin within 3 months of screening.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
21 Years
Maximum Age:
75 Years
Study:
NCT00099320
Study Brief:
Protocol Section:
NCT00099320